Discontinuing Tyrosine Kinase inhibitor (TKI) in patients suffering from chronic myeloid leukemia (CML) has shown better patient reported outcomes. from Medindia Health News https://ift.tt/3ok5Tru
No comments
Thanks for comment via will connect you within 24 hours.